Back to school: Tips to help you care for your child’s hands
With the arrival of Covid 19, hand hygiene guidance was introduced as one of the measures to reduce the spread of the coronavirus. Hand hygiene involves cleaning the hands with soap and water or hand sanitiser. Unfortunately, the increase in hand hygiene measures can lead to skin irritation, due to frequent skin contact with chemicals, […]
SECURE-AD Update: How do COVID-19 vaccinations affect patients with eczema?
The SECURE-AD patient survey is adapting to include the question, ‘How does the COVID-19 vaccination affect patients with eczema?’ In 2020, the SECURE-AD Patient survey was launched to understand how COVID-19 infections impacted on patients with eczema. The results will be available shortly as the research team are preparing their first scientific publication. Preliminary results […]
Watch our webinar on ‘The Future of Atopic Eczema Care in Ireland’
Did you miss our webinar on, The Future of Atopic Eczema Care in Ireland? No problem, watch it below. In this SkinSideOut webinar, our panel, eczema patient advocate, Paul Herriott; Consultant Dermatologist, Prof Alan Irvine; and Advanced Nurse Practitioner in Dermatology and ISF Clinical Helpline Manager, Carmel Blake talk about recent medical advancements in the […]
Webinar: The Future of Atopic Eczema Care in Ireland
This event has ended. In this SkinSideOut webinar, we take a look at The Future of Atopic Eczema Care in Ireland. You’ll hear about recent medical advancements in the treatment of eczema and what this will mean for the future; how COVID-19 has impacted dermatology services and how they have adapted to deliver care; and […]
BIOMAP project aims to improve lives of people with atopic dermatitis & psoriasis
BIOMAP have released a short animation which aims to demonstrate BIOMAP’s project work to alleviate the burden and consequences of AD and psoriasis for people living with these diseases. BIOMAP – Biomarkers in Atopic Dermatitis and Psoriasis What is BIOMAP? BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) is a large European project which launched in […]
First-in-class eczema drug dupilumab now available in Ireland
Life-changing biologic treatment, dupilumab, is now available to people with moderate to severe eczema in Ireland. The HSE has advised that effective from 1st April 2021, reimbursement of dupilumab will be available under High Tech Arrangements for the treatment of moderate-to-severe refractory atopic dermatitis (AD) in adults and adolescents 12 years and older for whom […]
Study for people aged 18-65, living with psoriasis, eczema or ichthyosis vulgaris
Are you aged 18-65 and living with psoriasis, eczema or ichthyosis vulgaris? You may be eligible to participate in a study to investigate the role of neutrophil proteases as global regulators of IL-1 family cytokine activity in skin disorders. NEUTROPRO Study The NEUTROPRO study is a research study being carried out by Professor Irvine (Dermatology […]
This Valentine’s Day, Love your Skin and Avoid an Eczema Flare
Our tips to avoid an eczema flare this Valentine’s Day! We know that some of you may be buying your loved one some special gifts or having a romantic date night in, so we’ve put together some tips to ensure an eczema flare doesn’t spoil your Valentine’s Day. Investing quality time If you plan on […]
Tips to Prepare for a Remote/Virtual Hospital Consultation
The ever-evolving COVID-19 situation has had an impact on society in many ways, which has meant that hospitals and dermatology departments have had to change the way they interact with their patients. In order to ensure ongoing treatment and continuity of care, patients may be offered a telephone or video call, instead of face-to-face appointments. […]
Update on Dupilumab: HSE Drugs Group Supports Reimbursement
Potentially life-changing treatment one step closer for people struggling with moderate-to-severe atopic eczema The HSE has advised that the HSE Drugs Group, the body which decides whether or not the Irish government will fund a new medicine through the public health system, supported reimbursement of dupilumab for a defined subgroup of the full licensed indication, […]
